IIR 2 340 0217 93/IRAQI BIOLOGICAL WARFARE RELATED

Filename:23400217.93a
ENVELOPE
CDSN = LGX733   MCN = 93007/02805   TOR = 930070134
RTTSZYUW RUEKJCS0435 0070128-    --RUEALGX.
ZNY 
HEADER
R 070128Z JAN 93
FM JOINT STAFF WASHINGTON DC
INFO RUEALGX/SAFE
R 061737Z JAN 93
FM [   (b)(1) sec 1.3(a)(4)   ]
TO AIG 12176
INFO RUEPNMO/CDR 513TH MI BDE FT MONMOUTH NJ//IAM-OB-IC-CM-H//
RUDGAAA/HQ AFTAC-IN PATRICK AFB FL//IN//
BT
CONTROLS

SECTION   001 OF 002


SERIAL:    (U) IIR 2 340 0217 93.

/*********** THIS IS A COMBINED MESSAGE ************/
BODY
COUNTRY:   (U) IRAQ (IZ).



SUBJ:      IIR 2 340 0217 93/IRAQI BIOLOGICAL WARFARE RELATED
FACILITY (U).

WARNING:   (U) THIS IS AN INFORMATION REPORT, NOT FINALLY 
EVALUATED
INTELLIGENCE.  REPORT CLASSIFIED 

-                      ---------------------

-                      DEPARTMENT OF DEFENSE

-                      ---------------------

DOI:       (U) 910730.

REQS:      (U) D-T5A-1610-02-90; SC-IA2-01482.

SOURCE:    [   (b)(1) sec 1.3(a)(4)   ][   (b)(7)(D)   ]



SUMMARY:         THE ANIMAL MEDICINE FACTORY WAS RESPONSIBLE FOR
RESEARCH, DEVELOPMENT AND HUMAN TESTING OF VARIOUS STRAINS OF
BIOLOGICAL WARFARE AGENTS.  SOURCE ACQUIRED INFORMATION PROVIDED 
IN
THIS REPORT THROUGH [   (b)(7)(D)   ]  PERSONAL RELATIONSHIP WITH 
AN INDIVIDUAL EMPLOYED AT THE BIOLOGICAL WARFARE RESEARCH FACILITY 
AT SALMAN PAK.

TEXT:  1.  [   (b)(1) sec 1.3(a)(4)   ][   (b)(7)(D)   ]   















2.   ANIMAL MEDICINE FACTORY--THE ANIMAL MEDICINE FACTORY WAS 
COLOCATED WITH, AND ACTUALLY RECOGNIZED AS, A PART OF THE 
VETERINARY COLLEGE, BAGHDAD, IRAQ.  THE ANIMAL MEDICINE FACTORY 
WAS LOCATED AT //UTMCOORD:  NI 48608580//, IN COMPLEX NUMBER 163 
ON DEFENSE MAPPING AGENCY CITY GRAPHIC, BAGHDAD, 1:25,000, EDITION 
6-DMA, K941, SHEET FOUR, PUBLISHED IN 1991.  (FLD CMT--SOURCE 
IDENTIFIED THE BUILDING AS THE 'L'-SHAPED FACILITY IN THE LOWER 
RIGHT PORTION OF COMPLEX 163.)  THE ANIMAL MEDICINE FACTORY (AMF) 
WAS INTIMATELY INVOLVED WITH SALMAN PAK BIOLOGICAL WARFARE 
RESEARCH FACILITY.  AMF WAS PRIMARILY RESPONSIBLE FOR THE 
DEVELOPMENT OF VARIOUS STRAINS OF PLAGUE AND CHOLERA.  (FLD 
CMT--SOURCE WAS CERTAIN OF THE EXISTENCE OF VECTOR-TYPE AGENTS BUT 
HAD NFI CONCERNING ALTERNATE DELIVERY MEANS FOR BW AGENTS.)  
SOURCE SPECULATED THAT AMF WAS FURTHER INVOLVED IN DEVELOPING 
YELLOW FEVER AND HEPATITIS STRAINS TO BE USED IN THE IRAQI BW 
PROGRAM.  AMF WAS ULTIMATELY RESPONSIBLE FOR TESTING THE FINISHED 
PRODUCTS.  ASIDE FROM LIVESTOCK AND RODENTS, HUMAN PRISONERS WERE 
USED IN TESTING OF BW AGENTS AT AMF.  (FLD CMT--TESTING OF BW 
AGENTS ON HUMAN PRISONERS IS HEARSAY INFORMATION OBTAINED FROM [  
 (b)(1) sec 1.3(a)(4)   ][   (b)(7)(D)   ]  
                                 



3.  (S/NF) PROJECT SUPERVISION--ALTHOUGH AMF WAS NOT DIRECTED BY 
UDAY ((HUSSEIN)), HE MONITORED THE ACTIVITY THERE CLOSELY.  UDAY 
TOOK AT LEAST TWO TRIPS TO BRAZIL VIA MOROCCO BETWEEN 1988 AND 
1991.  THESE TRIPS WERE ARRANGED TO PURCHASE A ROCKET OR MISSILE 
SYSTEM CAPABLE OF DELIVERING BW AGENTS INTO IRAN AND ISRAEL.  NFI.

COMMENTS:  1.  (U) QUESTIONS OR COMMENTS IN RESPONSE TO THIS IIR 
SHOULD BE FORWARDED TO CDR 2O2ND MI BN FT MONMOUTH 
NJ//IAM-C-OSD//. POC IS [   (b)(6)   ]DSN 992-6042/5680, 
COMMERCIAL (908) 532-6042/ 5680, E-MAIL ADDRESS 
IAM002@MONMOUTH-EMH3.ARMY.MIL.

//IPSP:  PT 1610//.
//COMSOBJ:  111; 321//.
ADMIN
PROJ:  (U) 2907.
INSTR:  (U) US NO.
PREP:  (U) 2-60027.
ACQ:  (U) FT MONMOUTH NJ (921117).
DISSEM:  (U) FIELD: NONE.
WARNING:  (U) REPORT CLASSIFIED